title: Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
authors.affiliation: Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
authors.forename: Moe
authors.initials: M
authors.lastname: Tsuda
authors.affiliation: Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan. hishimd@kuhp.kyoto-u.ac.jp.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ishiguro
authors.affiliation: Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
authors.forename: Ikuko
authors.initials: I
authors.lastname: Yano
authors.affiliation: Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
authors.forename: Masakazu
authors.initials: M
authors.lastname: Toi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology*; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D004164:Diphosphonates